-
硫唑嘌呤杂质B
- names:
Azathioprine EP Impurity B
- CAS号:
157930-13-7
MDL Number: - MF(分子式): C5H4N4S MW(分子量): 152.18
- EINECS: Reaxys Number:
- Pubchem ID: Brand:BIOFOUNT
| 货品编码 | 规格 | 纯度 | 价格 (¥) | 现价(¥) | 特价(¥) | 库存描述 | 数量 | 总计 (¥) |
|---|---|---|---|---|---|---|---|---|
| YPZZ62111-10mg | 10mg | 0.98 | ¥ 0.00 | ¥ 0.00 | Get quote | ¥ 0.00 |
| 中文别名 | 硫唑嘌呤杂质 ;(硝基)咪唑硫嘌呤杂质 |
| 英文别名 | 7H-Purine-6-thiol |
| CAS号 | 157930-13-7 |
| Inchi | InChI=1S/C5H4N4S/c10-5-3-4(7-1-6-3)8-2-9-5/h1-2H,(H2,6,7,8,9,10)CopyCopied |
| InchiKey | GLVAUDGFNGKCSF-UHFFFAOYSA-NCopyCopied |
| 分子式 Formula | C5H4N4S |
| 分子量 Molecular Weight | 152.18 |
| 溶解度Solubility | |
| 性状 | |
| 储藏条件 Storage conditions |
杂质产品注意事项:1、普通杂质产品需要提供核磁[氢谱、碳谱(如氢谱不能证明该化合物的情况下)]、LC-MS图谱、色谱图、手性化合物需要核磁二维图谱表征。
| 产品说明 | 硫唑嘌呤EP杂质B是合成硫唑嘌呤过程中产生多余的化学物质它会与药物活性成分(API)一起保留,这些有害化学物质的存在,可能影响药品的功效和安全性。 |
| Introduction | Azathioprine EP Impurity B is a impurity of Azathioprine . It will remain with the active pharmaceutical ingredients (API). The presence of these harmful chemicals may affect the efficacy and safety of the drug. |
| Application1 | |
| Application2 | |
| Application3 |
| 警示图 | |
| 危险性 | |
| 危险性警示 | 暂无数据 |
| 安全声明 | CAUTION: May irritate eyes, skin |
| 安全防护 | |
| 备注 |
| Allison Derenne, Régis Gasper and Erik Goormaghtigh.The FTIR spectrum of prostate cancer cells allows the classification of anticancer drugs according to their mode of action,Analyst, 2011, 136, 1134.[DOI: 10.1039c0an00872a] |
| Rajendra N. Goyal, Arshi Rastogi and Aditi Sangal.Electro-oxidation of 6-mercaptopurine riboside with special emphasis on the stability of the dimer in aqueous solutions,New J. Chem., 2001, 25, 545.[DOI: 10.1039b008387i] |
| Natalie R. AttardPresent address: Department of Dermatology, The Royal London Hospital, London, E1 1BB, UK and Peter Karran.UVA photosensitization of thiopurines and skin cancer in organ transplant recipients,Photochem. Photobiol. Sci., 2012, 11, 62.[DOI: 10.1039c1pp05194f] |
| Wenjing Wang, Chenjie Fang, Xiaozhu Wang, Yuxi Chen, Yaonan Wang, Wei Feng, Chunhua Yan, Ming Zhao and Shiqi Peng.Modifying mesoporous silica nanoparticles to avoid the metabolic deactivation of 6-mercaptopurine and methotrexate in combinatorial chemotherapy,Nanoscale, 2013, 5, 6249.[DOI: 10.1039c3nr00227f] |
| Ducati Rodrigo G., Basso Luiz A., Santos Diógenes S., de Azevedo Walter F..Crystallographic and docking studies of purine nucleoside phosphorylase from Mycobacterium tuberculosis,Bioorganic |
对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
- 相关产品
-
< >
- 推荐产品
-
< >
- 最新产品
-
< >
新闻
抱歉,暂无数据!


购物车 


